Appendix Table. Cross-tabulation of region of acquisition and ... - CDC

Recommend Documents

Yes, 406 (88.1). 13 (3.2) 1.78, 0.29â13.9 26 (6.4) 0.87, 0.29â2.59. 144. (35.4). 0.61, 0.33â1.13. No, 55 (11.9). 1 (1.8). Reference. 4 (7.3). Reference. 26 (47.3).

Appendix Table - CDC stacks

jaundice, cough, myalgia,. Fever, chills, headache, cough, relative bradycardia. Fever, chills, headache, relative bradycardia. Environmental or animal exposure.

Appendix Table - CDC

A/chicken/Shantou/810. DQ095766. DQ095746. DQ095726. DQ095626. DQ095686. DQ095666. DQ095646. DQ095706. A/chicken/Sudan/1784/10/2006.

Table of contents Appendix Figure S1. CDC-EVs and ...

EV-YF1 transfer in control NHDFs compared to CDCs. Appendix Figure S4. EV-YF1 modulates IL-10 expression. Appendix Figure S5. EV-YF1 induced direct ...

Appendix Table. Origin and PhenePlate types of 97 Escherichia ... - CDC

Emperor/Brent goose. Kolyuchin, Siberia. CT3. 62. Emperor/Brent goose. Kolyuchin, Siberia. CT3. 63. Emperor/Brent goose. Kolyuchin, Siberia. Si. 64.

Southern Indochina, Appendix Table | CDC EID

Dec 30, 2009 - Influenza A Viruses (H5N1), Southern Indochina, Appendix Table | CDC EID http://www.cdc.gov/EID/content/15/10/1641-appT.htm[12/30/2009 ...

Appendix Table. Characteristics of clonal isolates of ... - CDC

Oct 11, 1999 - 1. 403. A. O11. ST69. 2000 Jan 7. 0. 0. 0. 1. 431. A. O11. ST69. 2000 Jan 18. 0. 0. 0. 1. 470. A. O77. 2000 Jan 25. 0. 0. 0. 1. 476. A. 2000 Jan 25.

Appendix Table 4. Univariate sensitivity analyses of the death ... - CDC

Appendix Table 4. Univariate sensitivity analyses of the death from acute illness variable for the general population assessing the impact of this variable on the ...

Appendix Table 3. Univariate sensitivity analysis of the chronic ... - CDC

Appendix Table 3. Univariate sensitivity analysis of the chronic disease variable for pregnant women assessing the impact of this variable on the cases of severe ...

Appendix Table. Epidemiologic data of CTX-M-15-producing ... - CDC

C. 120. FII + FIA (120). B. B23. Canada,. Spain. Urine (n = 2). 2000–2002. C15–3c ... C15–14. 1. fumC 4 Ac, Cp, Na, Sm, Su, Tc, Tp. C. 120 + 100. FII + FIA + FIB.

Swine Workers and Swine Influenza Virus, Appendix Table | CDC EID

Swine influenza (H1N1), greatest increaseâ¡ n (%). Unadjusted OR .... Vaccinated at least 1 of last 2 winters but otherwise not since 2001. 168. 38. (22.6).

Appendix Table. Dengue stains and sequences used in ... - CDC

Dengue stains and sequences used in phylogenetic analysis. Dengue strain. Location. Year isolated. Accession no. Dengue 1 prototype. NA*. NA. NC_001477.

table of contents.fm - CDC

Henri Verbrugh, Bob LÃ¶wenberg, and Hubert Endtz. Erasmus University Medical Center ...... J-R, Coll I, Vidal D, et al. Emergence and dissemination of qui-.

Table of Contents - CDC

Kristen Blanchard. Jason Folster. Peter Gerner-Smidt ... Karim George. William Grooms .... Washington Department of Health. Jennifer Breezee. Romesh ...

Table of Contents - CDC

Table 25. Antimicrobial resistance of Shigella sonnei isolates, 1999-2001 . .... MICs among Shigella flexneri isolates, by antimicrobial agent, 1999-2001.

Table of Contents.fm - CDC

respiratory cultures sent to the Hawaii Department of Health and the number of providers ... Hawaii's influenza surveillance were not secondary to differences in ...

Appendix Table of contents: Appendix Figures S1 and S2 Appendix ...

Appendix Fig S1: Separation of function mutants are defective in ICL unhooking. A) XPF-. ERCC1 depleted (ÎXE) NPE or XPF-ERCC1 depleted NPE ...

Appendix Table of Contents

The Cancer Genome Atlas (TCGA) prostate cancer dataset was .... was carried out using the DESeq workflow (Anders & Huber, 2010). The raw and normalized ...

Appendix: Table of Contents

expressed as the concentration of IgG in ng/ml able to neutralize 90% of viral infectivity (IC90) and the reactivity of the antibodies in western blot (WB) under non-.

Appendix Table of Contents Appendix Figures and Legends Appendix

Appendix Figures and Legends. Appendix Figure S1 Disruption of CDKL5 in human U2OS Flp-Inâ¢ T-. RExâ¢ cells. Appendix Figure S2. Histograms and ...

1 Appendix Table of contents Appendix Figures

read counts across the time series (replicates averaged per time point) for each ... Appendix Figure S6 â Correlation of TT-seq signal for closest eRNAs with their.

Appendix table of contents Appendix Supplementary Methods

deoxycholate, 0.5% Igepal, EDTA-free Complete protease inhibitor cocktail (PIC; Roche,. 11873580001) ... (Appendix Supplementary Methods Figure S1B,C). .... v1.3(Martin, 2011), in paired-end mode (parameters: minimum read length: 18 nt, maximum ... R

APPENDIX Table of Contents: Appendix Supplementary Methods

RBPJ and L3MBTL3 co-localize at two distal HES1 enhancers. ChIP analyses of endogenous RBPJ and L3MBTL3 in U87-MG cells were performed for two ...

APPENDIX Table of Contents Appendix Supplementary Methods

used with oil immersion objective 100x/1.45, and dry objective 40x/0.95 was .... Quantitative Real-Time PCR (qRT-PCR) was carried out using SYBR Green ...

Appendix Table. Cross-tabulation of region of acquisition and ... - CDC

Download PDF

1 downloads 0 Views 38KB Size Report

Comment

ST. Sub-. Saharan. Africa. UK and. Ireland East Asia. Central and. Eastern. Europe ... America. Southern. Europe. Western. Europe. Total HA:CA (%,. 95% CI).

Appendix Table. Cross-tabulation of region of acquisition and sequence type for cases of methicillin-resistant Staphylococcus aureus acquired abroad and reported in Sweden, 2000–2003* SubCentral and North Africa, Oceania Saharan UK and Eastern Israel, Arabic North Northeastern and Pacific South Southern Western Total HA:CA (%, ST Africa Ireland East Asia Europe countries, Iran America Mediterranean Nordic islands America Europe Europe 95% CI) ST1 2 1 3 (27, 6–61) HA 3 1 4 (36, 11–69) CA ST5 HA 1 1 9 2 3 16 (67, 45–84) 1 2 1 4 (17, 5–37) CA ST8 HA 1 1 1 4 1 1 3 12 (39, 22–58) 1 4 5 1 3 14 (45, 27–64) CA ST22 15 1 1 1 3 21 (88, 68–97) HA CA 1 1 2 (8, 1–27) ST30 1 1 3 5 (18, 6–37) HA 13 2 1 3 19 (68, 48–84) CA ST36 HA 1 11 1 1 4 1 1 20 (95, 76–100) 0 CA ST45 1 1 1 3 6 (55, 23–83) HA 1 1 2 (18, 2–52) CA ST72 2 2 (25, 3–65) HA 6 6 (75, 35–97) CA ST80 HA 1 2 1 1 5 (8, 3–19) CA 2 2 2 18 21 1 46 (78, 48–84) ST88

Total 11

24

31

24

28

21

11

8

59

1 HA CA ST125

3

1

1 (20, 0.5–72)

5

4 (80, 28–99) 1

5

6 (75, 35–97)

8

HA 0 CA ST152 4

4 (67, 22–96)

2

2 (33, 4–78)

6

HA CA ST228 1

5

11

1

18 (95, 74–100)

19

HA 0 CA ST239 22

1

5

30

3

61 (94, 85–98)

65

HA 1

1 (2, 0.04–8)

CA ST241 4

5

1

1

11 (92, 62–100)

12

HA 0 CA Total HA:CA (%, 95% CI) HA 7 (39, 31 (94, 17–64) 80–94) CA 9 (50, 2 (6, 26–74) 1–20) Total 18 33

43 (47, 36–57) 37 (40, 30–51) 92

11 (46, 26–67) 9 (38, 19–59) 24

20 (40, 26–55) 20 (40, 26–55) 50

15 (71, 48–89) 5 (21, 7–42) 24

56 (62, 51–72) 29 (32, 23–43) 90

1 0 1

9 (53, 28–77) 3 (21, 5–51) 14

5 (42, 15–72) 4 (33, 10–65) 12

31 (86, 71–95) 0 36

15 (83, 59–96) 1 (6, 0.1–27) 18

244 (59, 54–64) 119 (29, 24–33) 414

*Shown are 414 independent cases (not belonging to the same transmission chain) of 444 cases acquired abroad. Cases are stratified as healthcare-acquired (HA) and community-acquired (CA) for each sequence type (ST) and region of acquisition. In some instances, numbers in rows and columns do not add up to the totals because of persons with STs other than the ones listed or because cases were indeterminable with regard to transmission setting. CI, confidence interval.